PV/Drug Safety Solutions for Pharma
Assyro AI empowers pharmacovigilance professionals in pharmaceutical companies with intelligent regulatory tools. Assyro AI supports pharmacovigilance professionals with regulatory intelligence on safety reporting requirements, signal detection, and risk management. Stay compliant with global PV obligations and evolving safety standards.
What PV/Drug Safety Teams Do
- Managing adverse event reporting and safety databases
- Preparing periodic safety reports (PSUR/PBRER)
- Conducting signal detection and safety surveillance
- Developing and maintaining risk management plans
- Ensuring compliance with global PV regulations
Challenges in Pharma
- Managing increasing volume of safety data and reports
- Tracking country-specific reporting requirements and timelines
- Keeping up with evolving pharmacovigilance regulations
- Cross-functional teams misalign on Module 2 summaries weeks before submission lock
- Manual eCTD assembly creates structural defects caught too late to fix cleanly
How Assyro AI Helps
- Track global pharmacovigilance regulations and requirements
- Monitor FDA and EMA safety-related announcements
- Generate safety documentation with AI assistance
- Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
- Validate eCTD sequences in real time against FDA technical specs before gateway dispatch
Key Skills We Support
Regulations We Cover
Frequently Asked Questions
Assyro AI provides PV teams with regulatory intelligence on global safety reporting requirements, signal detection guidance, and risk management frameworks. Our AI helps track changing PV regulations across markets.
Assyro AI assists with PSUR/PBRER preparation by tracking regulatory templates, timeline requirements, and content expectations. Our AI helps ensure your periodic safety reports meet current EMA and global standards.
Yes, Assyro AI covers pharmacovigilance regulations from FDA, EMA, PMDA, Health Canada, and other agencies. We track changes to reporting requirements, timelines, and format specifications.
Teams using Assyro draft regulatory documents 14x faster and cut validation time by 50%. On a typical NDA cycle, that translates to 100+ recovered hours and $150-250K in avoided rework, contractor fees, and delayed revenue.
Yes. Assyro supports all major FDA submission types with pre-configured workflows for each. The same execution system handles original applications, supplements, amendments, and annual reports.
Regulatory Context
PV/Drug Safety teams in Pharma depend on current regulatory intelligence to keep submissions, quality narratives, and inspection responses aligned with health-authority expectations.
Common Mistakes
- Running signal reviews on fixed schedules without event-triggered checks.
- Weak integration between safety findings and label/risk communication updates.
- Limited visibility into enforcement trends that predict agency scrutiny.
Key Regulatory Terms
Relevant Regulatory Intelligence
Related Actions
Other Roles in Pharma
PV/Drug Safety in Other Industries
Ready to Transform Your PV/Drug Safety Operations?
See how Assyro AI can accelerate regulatory work for pharmacovigilance professionals in pharmaceutical companies.
Schedule a Demo